Runway Growth Finance Corp. to Release Q1 2026 Financial Results
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 6 days ago
0mins
Should l Buy RWAY?
Source: Newsfilter
- Earnings Release Schedule: Runway Growth Finance Corp. will release its Q1 2026 financial results after market close on May 7, 2026, providing investors with insights into its latest financial status and operational performance.
- Conference Call Details: The company will hold a conference call on the same day at 2:00 PM PT (5:00 PM ET) to discuss the financial results, requiring investors to register in advance to ensure timely information dissemination.
- Webcast Replay Availability: A replay of the webcast will be available two hours after the call and archived on the same webpage for 90 days, allowing investors who cannot participate live to access the information later.
- Company Background: Runway Growth is a specialty finance company focused on providing flexible capital solutions to late- and growth-stage companies, aiming to offer alternatives to equity financing and enhance their market competitiveness.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy RWAY?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on RWAY
Wall Street analysts forecast RWAY stock price to rise
7 Analyst Rating
2 Buy
5 Hold
0 Sell
Moderate Buy
Current: 6.730
Low
9.00
Averages
10.57
High
12.00
Current: 6.730
Low
9.00
Averages
10.57
High
12.00
About RWAY
Runway Growth Finance Corp. is a specialty finance company. The Company is focused on providing senior secured loans to high growth-potential companies in technology, healthcare, business services, financial services, select consumer services and products and other high-growth industries. Its investment objective is to maximize its total return to its stockholders primarily through current income on the Company's loan portfolio and secondarily through capital gain (loss) on its warrants and other equity positions. The Company invests in senior secured term loans and other senior debt obligations, and it also invests in second lien loans issued by high growth-potential companies. The Company originates its investments through two strategies: Sponsored Growth Lending and Non-Sponsored Growth Lending. It also invests in secured loans, and acquires equity securities as well, including warrants. The Company is externally managed by Runway Growth Capital LLC (RGC).
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Runway Growth Finance Corp. to Release Q1 2026 Financial Results
- Earnings Release Schedule: Runway Growth Finance Corp. will release its Q1 2026 financial results after market close on May 7, 2026, providing investors with insights into its latest financial status and operational performance.
- Conference Call Details: The company will hold a conference call on the same day at 2:00 PM PT (5:00 PM ET) to discuss the financial results, requiring investors to register in advance to ensure timely information dissemination.
- Webcast Replay Availability: A replay of the webcast will be available two hours after the call and archived on the same webpage for 90 days, allowing investors who cannot participate live to access the information later.
- Company Background: Runway Growth is a specialty finance company focused on providing flexible capital solutions to late- and growth-stage companies, aiming to offer alternatives to equity financing and enhance their market competitiveness.
See More
Runway Growth Completes Acquisition of SWK Holdings, Expanding Healthcare Focus
- Acquisition Finalized: Runway Growth successfully closed its acquisition of SWK Holdings on April 6, 2026, for a total price of $249 million, comprising $75.5 million in Runway Growth shares and $173.5 million in cash, enhancing the company's investment capabilities and earnings potential.
- Portfolio Expansion: Following the acquisition, Runway Growth's total assets will reach $1.2 billion, with healthcare and life sciences investments increasing from 14% to approximately 32% as of December 31, 2025, accelerating the company's diversification in a rapidly growing market.
- Investment Activity Update: In Q1 2026, Runway Growth completed four investments totaling $17.6 million, including a new $7.5 million investment in HR Pharmaceuticals, demonstrating the company's ongoing commitment and growth potential in the medical products sector.
- Team Restructuring: David Spreng has returned as Chief Investment Officer, with the investment committee now including CFO Tom Raterman and BC Partners Credit partner Patrick Schafer, indicating a strategic reorganization and strengthening of leadership in investment management.
See More
Rai Way SpA Reports 2025 Earnings Highlights
- Revenue Growth: Rai Way SpA reported a 2.4% year-on-year revenue increase, exceeding EUR 282 million, primarily driven by contributions from anchor customer RAI and third-party clients, indicating the company's stability and growth potential in the market.
- Adjusted EBITDA Performance: The adjusted EBITDA reached EUR 191.8 million, an increase of over EUR 6 million compared to 2024, reflecting better-than-expected operational performance and enhancing investor confidence.
- Shareholder Return Policy: The company confirmed a dividend distribution of EUR 0.33 per share, representing a 100% payout of net income, demonstrating its commitment to shareholder returns and bolstering market confidence in its financial health.
- Sustainability Achievement: Rai Way SpA achieved carbon neutrality for Scope 1 and Scope 2 emissions, highlighting its commitment to sustainability, which may attract investors interested in environmental, social, and governance (ESG) factors.
See More
Runway Growth Finance Q4 2025 Earnings Analysis
- Investment Income Performance: Runway Growth Finance Corp reported total investment income of $30 million and net investment income of $11.6 million in Q4 2025, indicating potential despite a decline from the previous quarter, showcasing the company's investment potential in high-growth sectors.
- Loan Funding Situation: The company completed $42.9 million in funded loans across high-growth industries, reflecting the effectiveness of its investment strategy in technology, healthcare, and consumer sectors, which is expected to drive future revenue growth.
- Acquisition Impact: RWAY's pending acquisition of SWK Holdings is anticipated to diversify its portfolio, particularly enhancing exposure in healthcare and life sciences, thereby strengthening the company's competitive position in the market.
- Risk and Return: Although net investment income decreased from the previous quarter and the fair value of the investment portfolio fell by 2%, the company's debt portfolio generated an annualized yield of 14.2%, demonstrating its capability in risk management and income generation.
See More
Runway Growth Finance Corp. Reports Q4 2025 Earnings with Strategic Insights
- Investment Income Overview: Runway Growth Finance reported total investment income of $30 million and net investment income of $11.6 million in Q4 2025, indicating the company's capability to invest in high-growth sectors despite a decline compared to Q3.
- SWK Transaction Outlook: Management expects the SWK transaction to close in early April, and while there is a slight delay, this deal is anticipated to diversify the portfolio, particularly in health care and life sciences, enhancing future growth potential.
- Financial Metrics Changes: The fair value of the company's investment portfolio stood at $927.4 million, reflecting a 2% decrease from the previous quarter, while the NAV per share was $13.42, demonstrating the company's resilience and risk management amid market fluctuations.
- Operating Expenses and Earnings: Operating expenses for Q4 were $18.4 million, down from $21 million in Q3, indicating effective cost control measures by management, which also reflects their confidence in future earnings sustainability.
See More
Runway Growth (RWAY) Earnings Call Transcript
See More
Runway Growth Finance Corp. to Release Q1 2026 Financial Results
- Earnings Release Schedule: Runway Growth Finance Corp. will release its Q1 2026 financial results after market close on May 7, 2026, providing investors with insights into its latest financial status and operational performance.
- Conference Call Details: The company will hold a conference call on the same day at 2:00 PM PT (5:00 PM ET) to discuss the financial results, requiring investors to register in advance to ensure timely information dissemination.
- Webcast Replay Availability: A replay of the webcast will be available two hours after the call and archived on the same webpage for 90 days, allowing investors who cannot participate live to access the information later.
- Company Background: Runway Growth is a specialty finance company focused on providing flexible capital solutions to late- and growth-stage companies, aiming to offer alternatives to equity financing and enhance their market competitiveness.
See More
Runway Growth Completes Acquisition of SWK Holdings, Expanding Healthcare Focus
- Acquisition Finalized: Runway Growth successfully closed its acquisition of SWK Holdings on April 6, 2026, for a total price of $249 million, comprising $75.5 million in Runway Growth shares and $173.5 million in cash, enhancing the company's investment capabilities and earnings potential.
- Portfolio Expansion: Following the acquisition, Runway Growth's total assets will reach $1.2 billion, with healthcare and life sciences investments increasing from 14% to approximately 32% as of December 31, 2025, accelerating the company's diversification in a rapidly growing market.
- Investment Activity Update: In Q1 2026, Runway Growth completed four investments totaling $17.6 million, including a new $7.5 million investment in HR Pharmaceuticals, demonstrating the company's ongoing commitment and growth potential in the medical products sector.
- Team Restructuring: David Spreng has returned as Chief Investment Officer, with the investment committee now including CFO Tom Raterman and BC Partners Credit partner Patrick Schafer, indicating a strategic reorganization and strengthening of leadership in investment management.
See More
Rai Way SpA Reports 2025 Earnings Highlights
- Revenue Growth: Rai Way SpA reported a 2.4% year-on-year revenue increase, exceeding EUR 282 million, primarily driven by contributions from anchor customer RAI and third-party clients, indicating the company's stability and growth potential in the market.
- Adjusted EBITDA Performance: The adjusted EBITDA reached EUR 191.8 million, an increase of over EUR 6 million compared to 2024, reflecting better-than-expected operational performance and enhancing investor confidence.
- Shareholder Return Policy: The company confirmed a dividend distribution of EUR 0.33 per share, representing a 100% payout of net income, demonstrating its commitment to shareholder returns and bolstering market confidence in its financial health.
- Sustainability Achievement: Rai Way SpA achieved carbon neutrality for Scope 1 and Scope 2 emissions, highlighting its commitment to sustainability, which may attract investors interested in environmental, social, and governance (ESG) factors.
See More
Runway Growth Finance Q4 2025 Earnings Analysis
- Investment Income Performance: Runway Growth Finance Corp reported total investment income of $30 million and net investment income of $11.6 million in Q4 2025, indicating potential despite a decline from the previous quarter, showcasing the company's investment potential in high-growth sectors.
- Loan Funding Situation: The company completed $42.9 million in funded loans across high-growth industries, reflecting the effectiveness of its investment strategy in technology, healthcare, and consumer sectors, which is expected to drive future revenue growth.
- Acquisition Impact: RWAY's pending acquisition of SWK Holdings is anticipated to diversify its portfolio, particularly enhancing exposure in healthcare and life sciences, thereby strengthening the company's competitive position in the market.
- Risk and Return: Although net investment income decreased from the previous quarter and the fair value of the investment portfolio fell by 2%, the company's debt portfolio generated an annualized yield of 14.2%, demonstrating its capability in risk management and income generation.
See More
Runway Growth Finance Corp. Reports Q4 2025 Earnings with Strategic Insights
- Investment Income Overview: Runway Growth Finance reported total investment income of $30 million and net investment income of $11.6 million in Q4 2025, indicating the company's capability to invest in high-growth sectors despite a decline compared to Q3.
- SWK Transaction Outlook: Management expects the SWK transaction to close in early April, and while there is a slight delay, this deal is anticipated to diversify the portfolio, particularly in health care and life sciences, enhancing future growth potential.
- Financial Metrics Changes: The fair value of the company's investment portfolio stood at $927.4 million, reflecting a 2% decrease from the previous quarter, while the NAV per share was $13.42, demonstrating the company's resilience and risk management amid market fluctuations.
- Operating Expenses and Earnings: Operating expenses for Q4 were $18.4 million, down from $21 million in Q3, indicating effective cost control measures by management, which also reflects their confidence in future earnings sustainability.
See More
Runway Growth (RWAY) Earnings Call Transcript
See More
